plerixafor has been researched along with Allergic Encephalomyelitis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mueller, AM; Sadiq, SA; Yoon, BH | 1 |
| Flügel, A; Miljković, D; Momcilović, M; Mostarica-Stojković, M; Odoardi, F; Stanojević, Z | 1 |
2 other study(ies) available for plerixafor and Allergic Encephalomyelitis
| Article | Year |
|---|---|
Inhibition of hyaluronan synthesis protects against central nervous system (CNS) autoimmunity and increases CXCL12 expression in the inflamed CNS.
Topics: Adoptive Transfer; Animals; Anti-HIV Agents; Benzylamines; Central Nervous System; Chemokine CXCL12; Cyclams; Encephalomyelitis, Autoimmune, Experimental; Female; Gene Expression Regulation; Heterocyclic Compounds; Hyaluronic Acid; Inflammation; Mice; Rats; T-Lymphocytes, Regulatory; Th1 Cells | 2014 |
CXCL12 expression within the CNS contributes to the resistance against experimental autoimmune encephalomyelitis in Albino Oxford rats.
Topics: Animals; Benzylamines; CD11b Antigen; CD4 Antigens; Chemokine CXCL12; Cyclams; Encephalomyelitis, Autoimmune, Experimental; Freund's Adjuvant; Gene Expression; Heterocyclic Compounds; Immunization; Interferon-gamma; Interleukin-17; Multiple Sclerosis; Rats; Rats, Inbred Strains; Species Specificity; Spinal Cord; T-Lymphocytes; Tissue Extracts | 2011 |